Jean-Marie Eveillard - First Eagle U.S. Value Options Holdings (Q4 2016)

As of Dec 31, 2016, the First Eagle U.S. Value portfolio disclosed options positions in its latest SEC 13F filing reported on May 12, 2026. These filings include call and put options tied to underlying equity holdings, providing a deeper look at the fund's use of derivatives for exposure and hedging.

The reported options activity included 2 call contracts and 0 put contracts across companies such as Gilead Sciences, Inc. (GILD), Sarepta Therapeutics, Inc. (SRPT). Options positions can signal strategies around hedging risk, enhancing leverage, or adjusting portfolio exposure during market shifts.

Options Positions

Showing 2 of 2 positions.

Quarter Symbol Company Option Contracts Notional Value
Q4 2016 GILD Gilead Sciences, Inc. CALL 300 $75.00
Q4 2016 SRPT Sarepta Therapeutics, Inc. CALL 300 $1.00

Note: Notional value represents the total exposure of the options position.